These results corroborate that LXRα plays an essential role in protecting lipid homeostasis and indicate that small-molecule drug development targeted restoration of LXRα expression can ameliorate obesity-induced lipid disturbances. This evidence concerns the gene NR1H3 and obesity due to melanocortin 4 receptor deficiency.